Company / Cost of Revenue
IRONWOOD PHARMACEUTICALS INC Cost of Revenue History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$3.1M
FY2022
5-year range
$3.1M / $3.1M
FY2018-FY2022
Trend
-
vs FY2021
Sector context
#77 of 85
Health Care
What the data says
Among 85 Health Care companies, IRONWOOD PHARMACEUTICALS INC is in the top 9% for cost of revenue. Cost of Revenue has fluctuated over the past 6 years, ranging from $2M in FY2018 to $33M in FY2020.
Based on SEC 10-K filings.
$3M in FY2022 with a 5-year CAGR of -30.3%.
Improved from $24M to $3M over the past 3 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -49.2%
- 5-Year CAGR
- -30.3%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 85This company $3.1M Sector average $2.0B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -30.3%, indicating a declining trend.
- Ranks #77 out of 85 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2020.
- Lowest cost of revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $3.1M | - |
| FY2021 | - | - |
| FY2020 | $32.8M | +37.2% |
| FY2019 | $23.9M | +1178.1% |
| FY2018 | $1.9M | -90.2% |
| FY2017 | $19.1M | +922.3% |
| FY2016 | $1.9M | +15466.7% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026